Ha Tay Pharmaceutical JSC Statistics

Total Valuation

Ha Tay Pharmaceutical JSC has a market cap or net worth of VND 7.12 trillion. The enterprise value is 7.44 trillion.

Market Cap	7.12T
Enterprise Value	7.44T

Important Dates

The last earnings date was Tuesday, January 21, 2025.

Earnings Date	Jan 21, 2025
Ex-Dividend Date	Oct 30, 2024

Share Statistics

Ha Tay Pharmaceutical JSC has 82.34 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	82.34M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	3.17%
Owned by Institutions (%)	n/a
Float	46.84M

Valuation Ratios

The trailing PE ratio is 99.24.

PE Ratio	99.24
Forward PE	n/a
PS Ratio	3.41
PB Ratio	6.92
P/TBV Ratio	6.93
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 71.71, with an EV/FCF ratio of -64.59.

EV / Earnings	103.66
EV / Sales	3.57
EV / EBITDA	71.71
EV / EBIT	89.34
EV / FCF	-64.59

Financial Position

The company has a current ratio of 1.20, with a Debt / Equity ratio of 0.44.

Current Ratio	1.20
Quick Ratio	0.41
Debt / Equity	0.44
Debt / EBITDA	4.85
Debt / FCF	-4.08
Interest Coverage	5.69

Financial Efficiency

Return on equity (ROE) is 7.08% and return on invested capital (ROIC) is 3.09%.

Return on Equity (ROE)	7.08%
Return on Assets (ROA)	2.54%
Return on Capital (ROIC)	3.09%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.11
Inventory Turnover	4.12

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +247.39% in the last 52 weeks. The beta is 0.45, so Ha Tay Pharmaceutical JSC's price volatility has been lower than the market average.

Beta (5Y)	0.45
52-Week Price Change	+247.39%
50-Day Moving Average	89,920.00
200-Day Moving Average	65,784.00
Relative Strength Index (RSI)	43.99
Average Volume (20 Days)	95,476

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ha Tay Pharmaceutical JSC had revenue of VND 2.09 trillion and earned 71.77 billion in profits. Earnings per share was 871.65.

Revenue	2.09T
Gross Profit	219.82B
Operating Income	76.51B
Pretax Income	95.22B
Net Income	71.77B
EBITDA	96.99B
EBIT	76.51B
Earnings Per Share (EPS)	871.65

Full Income Statement

Balance Sheet

The company has 180.27 billion in cash and 470.19 billion in debt, giving a net cash position of -289.92 billion or -3,520.97 per share.

Cash & Cash Equivalents	180.27B
Total Debt	470.19B
Net Cash	-289.92B
Net Cash Per Share	-3,520.97
Equity (Book Value)	1.06T
Book Value Per Share	12,503.56
Working Capital	157.11B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 27.96 billion and capital expenditures -143.13 billion, giving a free cash flow of -115.17 billion.

Operating Cash Flow	27.96B
Capital Expenditures	-143.13B
Free Cash Flow	-115.17B
FCF Per Share	-1,398.74

Full Cash Flow Statement

Margins

Gross margin is 10.54%, with operating and profit margins of 3.67% and 3.44%.

Gross Margin	10.54%
Operating Margin	3.67%
Pretax Margin	4.56%
Profit Margin	3.44%
EBITDA Margin	4.65%
EBIT Margin	3.67%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1,000.00, which amounts to a dividend yield of 1.16%.

Dividend Per Share	1,000.00
Dividend Yield	1.16%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	111.73%
Buyback Yield	n/a
Shareholder Yield	1.16%
Earnings Yield	1.01%
FCF Yield	-1.62%

Dividend Details

Stock Splits

The last stock split was on June 23, 2023. It was a forward split with a ratio of 2.8.

Last Split Date	Jun 23, 2023
Split Type	Forward
Split Ratio	2.8

Scores

Ha Tay Pharmaceutical JSC has an Altman Z-Score of 4.42.

Altman Z-Score	4.42
Piotroski F-Score	n/a